MICHAEL L. WARNER's scientific contributions

Publications (2)

Article
Women generally regard their hair loss as socially unacceptable and go to great measures to conceal their problem. In some cases, the negative self-image brought about by hair loss may be the basis of psychiatric illness. The purpose of this study was to evaluate a 2% topical minoxidil solution (Rogaine/Regaine, The Upjohn Co, Kalamazoo, Mich) for...
Article
Androgenetic alopecia is the most common cause of hair loss in men and women. Androgenetic alopecia in women begins as a diffuse and progressive thinning of the frontoparietal area of the scalp. In women, hair loss at any age is socially unacceptable and may be the basis of psychiatric illness. A 32-week, double-blind, placebo-controlled trial was...

Citations

... In an experiment in which minoxidil was applied to the hair loss area, hair growth was promoted not only in men but also in women [33]. However, when 5% minoxidil was used, the color of the cilia became darker and thicker, resulting in hirsutism [34]. ...
... Minoxidil is FDA-approved as a treatment for androgenetic alopecia [2,44]. It has been shown that a mechanism of minoxidil inducing hair growth is via stimulation of vascular endothelial growth factor (VEGF), which plays a role in promoting angiogenesis as well as influencing cell survival and proliferation [45]. ...